Teva Branded Pharmaceutical Products R&d Llc

This early-stage study tested a new drug called modakafusp alfa, given through a vein, in combination with other treatments for adults with multiple myeloma. The main goals were to find the safest dose and to monitor side effects. The trial was terminated early, but it gathered i…

This study tested a new drug called modakafusp alfa in people with multiple myeloma that had come back or stopped responding to other treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was stopped early, but the results help researcher…

This study tested a new drug (modakafusp alfa) combined with a standard treatment (daratumumab) in 15 people with multiple myeloma that had returned or stopped responding to prior therapies. The main goals were to check safety and find the best dose. The study was terminated earl…